chlorpheniramine has been researched along with Breast Neoplasms in 3 studies
Chlorpheniramine: A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.
chlorphenamine : A tertiary amino compound that is propylamine which is substituted at position 3 by a pyridin-2-yl group and a p-chlorophenyl group and in which the hydrogens attached to the nitrogen are replaced by methyl groups. A histamine H1 antagonist, it is used to relieve the symptoms of hay fever, rhinitis, urticaria, and asthma.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Proliferation of both mouse and human breast cancer cells was inhibited by chlorpheniramine (CPA) in a dose-response manner." | 7.69 | Chlorpheniramine inhibits the synthesis of ornithine decarboxylase and the proliferation of human breast cancer cell lines. ( García de Veas, R; Lozano, J; Medina, MA; Morata, P; Sánchez-Jiménez, F, 1995) |
| "The cytotoxic agents chlorpheniramine and dehydrodidemnin B decreased the cell growth of estrogen receptor-negative human breast cancer cells MDA-MB231 and estrogen receptor-positive MCF-7, after 48 h treatment." | 7.69 | Polyamine contents of human breast cancer cells treated with the cytotoxic agents chlorpheniramine and dehydrodidemnin B. ( de Pedro, E; Gómez-Fabre, PM; Márquez, J; Medina, MA; Núñez de Castro, I, 1997) |
| "Proliferation of both mouse and human breast cancer cells was inhibited by chlorpheniramine (CPA) in a dose-response manner." | 3.69 | Chlorpheniramine inhibits the synthesis of ornithine decarboxylase and the proliferation of human breast cancer cell lines. ( García de Veas, R; Lozano, J; Medina, MA; Morata, P; Sánchez-Jiménez, F, 1995) |
| "The cytotoxic agents chlorpheniramine and dehydrodidemnin B decreased the cell growth of estrogen receptor-negative human breast cancer cells MDA-MB231 and estrogen receptor-positive MCF-7, after 48 h treatment." | 3.69 | Polyamine contents of human breast cancer cells treated with the cytotoxic agents chlorpheniramine and dehydrodidemnin B. ( de Pedro, E; Gómez-Fabre, PM; Márquez, J; Medina, MA; Núñez de Castro, I, 1997) |
| "Trastuzumab is a standard treatment in breast cancer overexpressing Her2 oncogene." | 1.40 | Successful readministration of trastuzumab after severe immune reactions in two breast cancer patients. ( Chargari, C; Libert, N; Magne, N; Meillan, N; Tanz, R; Vedrine, L, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanz, R | 1 |
| Meillan, N | 1 |
| Libert, N | 1 |
| Magne, N | 1 |
| Vedrine, L | 1 |
| Chargari, C | 1 |
| Medina, MA | 2 |
| García de Veas, R | 1 |
| Morata, P | 1 |
| Lozano, J | 1 |
| Sánchez-Jiménez, F | 1 |
| Gómez-Fabre, PM | 1 |
| de Pedro, E | 1 |
| Núñez de Castro, I | 1 |
| Márquez, J | 1 |
3 other studies available for chlorpheniramine and Breast Neoplasms
| Article | Year |
|---|---|
Successful readministration of trastuzumab after severe immune reactions in two breast cancer patients.
Topics: Adult; Anaphylaxis; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Comb | 2014 |
Chlorpheniramine inhibits the synthesis of ornithine decarboxylase and the proliferation of human breast cancer cell lines.
Topics: Animals; Breast Neoplasms; Cell Division; Chlorpheniramine; Colonic Neoplasms; Dose-Response Relatio | 1995 |
Polyamine contents of human breast cancer cells treated with the cytotoxic agents chlorpheniramine and dehydrodidemnin B.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Chlorpheniramine; Depsipeptides; Female; Hum | 1997 |